Cure Pharmaceutical Holding Corp. Note Agreements

14 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of 9% Convertible Promissory Note, dated March 20, 2018
Note Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
NY
2018
Senior Secured Note between the Company and Ionic Ventures, LLC
Note Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
2024
Form of Note dated as of June 28, 2024, issued by the Company to the investor
Note Agreements
Cure Pharmaceutical Holding Corp.
2024
Promissory Note, dated July 22, 2022, issued by Buyer for the benefit of CURE Pharmaceutical
Note Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
CA
2022
Secured Promissory Note
Note Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
NY
2020
Note Purchase Agreement
Note Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
NY
2020
Series B Convertible Note
Note Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
DE
2020
Series A Convertible Note
Note Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
NY
2020
Secured Promissory Note, dated September 25, 2020, by and between CURE Pharmaceutical Holding Corp. and Ionic Ventures, LLC
Note Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
2020
Secured Promissory Note
Note Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
CA
2020
Convertible Promissory Note dated November 12, 2019
Note Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
CA
2019
Convertible Demand Note Issued by Cure Pharmaceutical Holding Corp. to Chemistry Holdings, Inc
Note Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
DE
2019
Form of Securities Purchase Agreement, by and between the Company and the Investors, with the form of Note
Note Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
NY
2018
Form of Securities Purchase Agreement between CURE Pharmaceutical Holding Corp. and various investors for up to $5,000 in convertible promissory notes, dated March 20, 2018
Note Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
NY
2018